# Selligy

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/selligy

- Industry: Software
- Headquarters: Belmont, US
- Website: www.selligy.com
- Total disclosed funding: $2.8M
- Latest round: Series A (Nov 13, 2013)
- Investors on record: 3

## About

Selligy develops cloud-based software solutions to enhance the efficiency of sales teams in the life sciences sector, offering tools that streamline workflows and improve sales activities.Founded in 2011 and headquartered in Belmont, US, Selligy specializes in software solutions for the life sciences industry. The company was sold to Veeva Systems in July 2015 for an undisclosed amount. The firm has been involved in 2 deals, with its most recent funding round being the Series A, where it raised USD 2.80 mn from lead investor Draper Fisher Jurvetson among others. The founder's history is not specified.Selligy primarily offered cloud-based software solutions designed to enhance the productivity of sales teams within the life sciences sector. The core offerings included Selligy Pursuit and Selligy Mobile, which provided tools for managing customer relationships and sales activities effectively. Released prior to their acquisition by Veeva Systems, these products aimed to streamline workflows, allowing users to track interactions with clients, manage schedules, and access sales data from mobile devices. The target clientele encompassed pharmaceutical and biotechnology companies requiring integrated solutions for sales force automation. Selligy’s products were operational in various geographical markets, including North America and Europe, where life sciences organizations sought innovative solutions to optimize their sales processes.Selligy operated on a subscription-based revenue model, generating income primarily through annual licensing agreements for access to its software products. Clients typically entered into contracts that included tiered pricing structures based on the number of users and the features desired, allowing for scalability as client needs evolved. Transactions were structured as B2B partnerships, with sales teams within life sciences firms leveraging Selligy's solutions to enhance their operational efficiency. The company’s flagship products, Selligy Pursuit and Selligy Mobile, formed the backbone of this transaction model, providing critical functionalities that drove user engagement and retention. Revenue was generated through these subscription fees, which were contingent upon the ongoing use and support of the software products provided.Selligy’s future growth strategy includes potential developments in new software products aimed at further enhancing sales team productivity. While specific launch dates are not disclosed, the company is anticipated to explore expansion opportunities in new geographic regions post-acquisition by Veeva Systems. The USD 2.80 mn raised during the Series A funding round will likely support these strategic initiatives. Following its acquisition, Selligy plans to leverage Veeva's broader market reach to enhance its offerings within the life sciences sector.

## Funding rounds

- Series A, Nov 13, 2013, $2.8M — Draper Fisher Jurvetson, Salesforce, Inc., Alchemist Accelerator

## Investors

- Draper Fisher Jurvetson (https://capitalatlas.ai/funds/draper-fisher-jurvetson) — Series A
- Salesforce, Inc. — Series A
- Alchemist Accelerator (https://capitalatlas.ai/funds/alchemist-accelerator) — Series A